SICURANZA ANNA

Anna
Sicuranza
Ricercatore Legge 240/10 - tempo determinato

Attività di ricerca

Ultime pubblicazioni:

  • Pacelli, P., Santoni, A., Sicuranza, A., Abruzzese, E., Giai, V., Crugnola, M., et al. (2023). Prospective monitoring of Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation: the fate of Peripheral Blood CD26+ Leukemia Stem Cells. FRONTIERS IN PHARMACOLOGY, 14, 1-11 [10.3389/fphar.2023.1194712]. - dettaglio
  • Gozzetti, A., Bacchiarri, F., Raspadori, D., Sicuranza, A., Sammartano, V., Bocchia, M. (2023). Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency. REVIEWS ON RECENT CLINICAL TRIALS [10.2174/0115748871241817230919062313]. - dettaglio
  • Cencini, E., Sicuranza, A., Ciofini, S., Fabbri, A., Bocchia, M., Gozzetti, A. (2023). Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications. CURRENT ONCOLOGY, 30(7), 6111-6133 [10.3390/curroncol30070455]. - dettaglio
  • Pacelli, P., Sicuranza, A., Bestoso, E., Iurlo, A., Abruzzese, E., Santoni, A., et al. (2023). Circulating CD34+/CD38-/CD26+ Leukemia Stem Cells along Chronic Myeloid Leukemia progression: differences between Chronic, Accelerated and Blast Phase. HEMATO, 1-8 [10.20944/preprints202304.0616.v1]. - dettaglio
  • Santoni, A., Malchiodi, M., Zappone, E., Sicuranza, A., Bocchia, M. (2023). Infectious complications after induction chemotherapy with FLAI(E) in newly diagnosed AML, omitting antibacterial prophylaxis. LEUKEMIA, 1-3 [10.1038/s41375-023-01930-z]. - dettaglio